FDA 510(k) Review Timeline: What to Expect and How to Prepare

FDA's stated goal for 510(k) review is 90 days from the date of acceptance. In practice, the median total time from submission to clearance for a standard 510(k) is closer to 160-200 days. For devices with significant technological complexity or novel intended uses, 300+ days is not uncommon.

Understanding what drives this gap — and what you control — is the difference between planning a realistic launch timeline and being blindsided by a six-month delay.

The timeline in phases

Phase 1: Pre-submission preparation (your timeline — typically 3-12 months)

This is everything before you file: predicate selection, testing, writing, and internal review. The quality of this work determines everything that follows. Submissions that enter FDA review with a strong predicate argument and complete performance data move through review fastest.

Phase 2: Acceptance review (15 days)

FDA performs an administrative check to confirm the submission contains all required elements. If it doesn't, FDA issues a Refuse to Accept (RTA) and your clock resets. Common RTA triggers: missing labeling, incomplete performance summary, wrong submission type.

Phase 3: Substantive review (FDA goal: 90 days from acceptance)

A lead reviewer evaluates your submission. This is where the substantial equivalence determination is made. During this phase FDA may issue an Additional Information (AI) request — a list of questions or requests for data that must be answered before review can continue.

Phase 4: AI response and re-review (your timeline — typically 30-90 days)

The AI clock stops while FDA waits for your response. A well-organized, complete AI response restarts the clock and typically leads to clearance within 30-45 days. An incomplete or evasive AI response generates a second AI request — and a second delay.

What drives Additional Information requests

AI requests are the primary cause of extended review timelines. The most common triggers:

• Predicate mismatch — FDA doesn't agree that the predicate supports the intended use or technological characteristics claimed
• Missing performance data — a technological difference that raises safety questions isn't supported by bench, animal, or clinical data
• Software gaps — insufficient documentation of software development lifecycle, hazard analysis, or verification and validation for software-containing devices
• Biocompatibility gaps — new materials without ISO 10993 assessment, or assessments that don't cover the right contact duration or tissue type
• Sterility gaps — sterile devices without a 510(k)-accepted sterilization method properly validated
• Labeling errors — intended use statement in labeling doesn't match Section 4 comparison

Review time by device category

Review times vary significantly by FDA panel. Historically, devices reviewed by the Cardiovascular panel have longer average review times than those reviewed by the General Hospital panel, reflecting the higher complexity of cardiovascular submissions. Software as a Medical Device submissions have seen increasing review times as FDA's SaMD review processes have evolved.

Before filing, look at clearance dates for recent predicate devices in your product code. The gap between submission date and clearance date — available in FDA's 510(k) database — gives you a realistic benchmark for your category. A product code with an average 140-day clearance history is different from one averaging 280 days.

How to build a realistic launch timeline

Work backwards from your target launch date:

• Research average clearance time for your product code from recent 510(k) data
• Add 30-60 days buffer for a likely AI request
• Add 30-45 days for post-clearance activities (labeling updates, manufacturing changes, distribution setup)
• Work backward from that total to set your submission date
• Work backward from submission date to set your testing completion date

Most first-time 510(k) filers underestimate the time from testing completion to submission by 2-3 months. Technical writing, internal review, regulatory consultant review, and eSTAR assembly all take time. Build those in explicitly.

The single best thing you can do for timeline

Get your predicate right before you start testing. The predicate determines what tests you need. Testing to the wrong predicate — or discovering a better predicate after testing is complete — means either refiling with a gap in your data package or repeating tests. Either option adds months.

A week spent on rigorous predicate research before testing begins is worth several months of accelerated review on the other end.